Alpha-lipoic acid (ALA) also know as thioptic acid, is a molecule that has confirmed over time its antioxidant properties, as well as properties in the treatment of diabetic neuropathy with a daily dosage of 2×300 mg, only in the case of a retard formulation.

Several studies on patients with DIABETIC NEUROPATHY have shown that ALA is able to significantly reduce pain and paraesthesia significantly.

ALA CRONO COMPLEX + NUCLEOTIDES EXCEEDS THE LIMIT OF BIOAVAILABILITY typical of Lipoic Acid thanks to the MATRIS patent.
The Matris patent guarantees the absorption of over 85% of the active ingredient within 9 hours, this means that the administration of two tablets certainly provides optimal daily coverage.

The kinetic variations obtained with MATRIS technology have a significant influence on the quality of the product.
The better bioavailability of the lipoic acid obtained makes ALA CRONO COMPLEX + NUCLEOTIDES a better “antioxidant” strategy in the indications for which it is intended to be used.

To complete the formula of ALA CRONO COMPLEX + NUCLEOTIDES, Nervonic Acid which is essential for the biosynthesis of the myelin sheath of nerve cells, Vitamins of group B (B3, B6, B12) for a good functioning of the nervous system, Vitamin E which contributes to protection of cells from oxidative stress and Nucleotides that guarantee, in the intestine, up to 3 times the absorption of the active ingredients present in the formula.

*NVR Daily amount values adult-Reg UE 1169/2011